Making diagnostic testing for Cardio, Metabolic and Renal disease as accessible as possible, to prevent these diseases from crippling health systems all over the world.  

PocDoc is an app-based technology platform that combines proprietary, patented Microfluidic Assay (MFA) technology and cloud-based AI diagnostics to deliver end-to-end digital pathways for the assessment, diagnosis and treatment of major diseases. 

PocDoc’s patented MFA (Microfluidic Assay) Platform is the first, truly portable, quantitative, digital diagnostic test platform that can perform complex multi-marker interactions to a clinically valid standard.

PocDoc’s 10-step AI diagnostic pipeline (HUESnap®) is capable of accurate colorimetric quantification of multiple biomarkers in the field from a single assay, producing clinically valid concentration predictions in seconds.

The PocDocOS® platform provides the digital infrastructure for the future of point of care testing. Using machine learning, data and process integration, dynamic workflows, clinical teams and real-time alerting, PocDocOS enables anyone with a smartphone or tablet to receive a full health assessment and critical follow on services, including speaking to a clinician, notifying your GP, sending your results to your patient record and providing real-time treatment options to do in minutes what could otherwise take weeks - or never.